Search

everythinglearnresearchcommunity

for

Search:↓

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Proper education can prevent traction alopecia in women of color.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Zinc helps manage skin disorders and deficiencies can worsen some conditions.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Betamethasone is more effective than Tacrolimus and soft paraffin for hair regrowth in patchy alopecia areata.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Placental extracts have antioxidant, anti-inflammatory, and immune-boosting effects, but their exact workings are unclear.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

A combined treatment with microneedling and vitamin D3 led to complete hair regrowth in a woman with stubborn patch alopecia areata.

Targeting specific cell interactions may help treat skin fibrosis.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Current treatments for alopecia areata can help hair grow but don't cure the disease.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Various treatments exist for hair loss, but no definitive solution.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.